drugset / Trial / NCT00869596

Study of Biomarkers of Airway Inflammation (0000-128)

NCT00869596

Phase 1 Completed 22 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindDiagnostic

Summary

This study will evaluate the effects of inhaled fluticasone on cell counts and inflammatory mediators measured in sputum of healthy volunteers following exposure to inhaled lipopolysaccharide.

Timeline

Start
2009-03
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 440 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 1980 ug Inhaled
Comparator Salbutamol Unknown 100 ug Inhaled